Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report

Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report

Few data are available regarding the effectiveness of anti-SARS-CoV-2 vaccine in immunocompromised patients. Vaccination may have a suboptimal efficacy in this population, in particular if patients are exposed to anti-B-cell therapy. We report the virological and clinical characteristics of a patien...

Full description

Bibliographic Details
Main Authors: Federica Calò, Lorenzo Onorato, Mariantonietta Pisaturo, Antonio Pinto, Loredana Alessio, Caterina Monari, Carmine Minichini, Manuela Arcamone, Alessandra Di Fraia, Luigi Atripaldi, Claudia Tiberio, Nicola Coppola
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Vaccines
Subjects:
SARS-CoV-2
COVID-19
oncohematological diseases
anti-B cells monoclonal antibodies
mRNA vaccine
relapse
Online Access:https://www.mdpi.com/2076-393X/10/7/1021

Internet

https://www.mdpi.com/2076-393X/10/7/1021

Similar Items